StriodeRestoring inner-ear physiology
NEW PATHWAYS. NEW POSSIBILITIES.

Working toward
restoring inner-ear
physiology

Striode is a company that aims to gain access to the inner-ear and restore its physiology. In doing so, we primarily aim to treat patients with debilitating vertigo and hearing loss seen in Ménière’s Disease. The technology will eventually be applicable to inner-ear drug delivery and treating other types of hearing loss.

Explore our vision
THE MEANING BEHIND STRIODE

Our name reflects
our purpose.

“Stri-” refers to the stria vascularis (the energy generator of the inner ear), and “-ode” means pathway. Our company’s technology aims to take over the physiology and function of the inner-ear battery.

01 THE OPPORTUNITY
Stylized inner-ear with gray semicircular canals and a red cochlea

A small structure.
A world of possibility.

The cochlea is a small, spiral-shaped structure in the inner ear. Within it, sensory cells help turn sound vibrations into signals that the brain interprets as sound.

At Striode, our research begins with the goal of restoring inner-ear function for patients with Ménière’s Disease. We are exploring how new approaches to inner-ear access could create a pathway toward that goal.

Explore the science of hearing · NIH ↗
02 OUR FOCUS

Restoring function.
Beginning with access.

Our company’s technology aims to take over the physiology and function of the inner-ear battery.

Research today.Possibility for tomorrow.
03 LOOKING AHEAD

An initial focus.
A broader future.

01 / DELIVERY

A pathway for
medication.

Beyond our initial focus on Ménière’s Disease, we aim to extend the technology to inner-ear drug delivery, creating new pathways for medications to reach the inner-ear.

02 / HEARING

New possibilities
for hearing loss.

We envision future applications in treating other types of hearing loss, building on our work to access the inner ear and restore its physiology.

These are research directions under development, not claims of demonstrated clinical performance.